Journal: Pathology

Article Title: Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing

doi: 10.1016/j.pathol.2018.08.012

Figure Lengend Snippet: Flow diagram describing the process of selection of appropriate specimens for the study. Specimens received with a request for ‘respiratory PCR’ were assessed for eligibility during both the pre-implementation and post-implementation periods. Specimens were excluded if the patient was admitted under the Oncology, Haematology or Bone Marrow Transplant unit, had a hospital length of stay (LOS) greater than 48 h at the time of specimen request, were private patients or outpatients, or had duplicate or inappropriate specimens (only nasopharyngeal swabs or aspirates were accepted). After applying exclusions, 200 specimens were included for the pre-implementation phase. These specimens had the in-house respiratory PCR performed. During the post-implementation phase, 124 specimens were included following exclusion. These specimens had both in-house respiratory PCR and FilmArray performed.

Article Snippet: This was a prospective study at the Royal Melbourne Hospital (RMH, Parkville, Australia) comparing clinical, hospital and laboratory parameters for 6 weeks before (2 July–30 August 2016) and after (21 September–20 October 2016) implementation of the Biofire FilmArray Respiratory Panel (Biomerieux, France) for diagnosis of respiratory pathogens.

Techniques: Selection